as on October 18, 2025 at 1:27 am IST
Day's Low
Day's High
0.25%
Downside
-0.25%
Upside
52 Week's Low
52 Week's High
37.68%
Downside
33.28%
Upside
Check Vtv Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$81.9M
EPS (TTM)
-3.645
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-25.6M
Revenue (TTM)
17.0K
Profit Margin
0.00%
Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Vtv Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $81.9M | -70.42% | NA | 0.00% | |
BUY | $63.1B | 231.27% | -505.15 | -12.96% | |
NA | $36.7B | NA | NA | -3.89% | |
BUY | $104.8B | 91.13% | 29.04 | 31.86% | |
BUY | $60.3B | -3.62% | 14.35 | 31.37% |
The Vtv Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Vtv Therapeutics Inc investment value today
Current value as on today
₹1,48,005
Returns
₹48,005
(+48.01%)
Returns from Vtv Therapeutics Inc Stock
₹43,211 (+43.21%)
Dollar Returns*
₹4,794 (+4.79%)
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Vtv Therapeutics Inc. Average target price of $35.5
Get share price movements and forecasts by analysts on Vtv Therapeutics Inc.
What analysts predicted
42.96%UPSIDE
Target Price
$35.5
Current Price
$20.25
Analyzed by
7 Analysts
Target
$35.50
Vtv Therapeutics Inc target price $35.5, a slight upside of 42.96% compared to current price of $20.25. According to 7 analysts rating.
Search interest for Vtv Therapeutics Inc Stock has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 148.2% return, outperforming this stock by 186.5%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.8% return, outperforming this stock by 19.7%
Price Dip
In the last 7 days, VTVT stock has moved down by -7.5%
Organisation | Vtv Therapeutics Inc |
Headquarters | 3980 Premier Drive, High Point, NC, United States, 27265 |
Industry | Health Technology |
CEO | Mr. Paul J. Sekhri M.Sc. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Richard S. Nelson | Executive VP of Corporate Development & Director |
Dr. Thomas Strack M.D., Ph.D. | Chief Medical Officer |
Mr. Martin Lafontaine | Chief Commercial Officer |
Mr. Paul J. Sekhri M.Sc. | CEO, President & Chairman of the Board |
Dr. Michael Steven Tung M.B.A., M.D. | Executive VP & CFO |
Mr. Barry K. Brown | Chief Accounting Officer |
Dr. Carmen Valcarce Ph.D. | Chief Scientific Officer & Executive VP |
Ms. Elizabeth M. Keiley | Executive VP & General Counsel |
Vtv Therapeutics Inc share price today is $20.25 as on at the close of the market. Vtv Therapeutics Inc share today touched a day high of $20.2 and a low of $20.2.
Vtv Therapeutics Inc share touched a 52 week high of $26.99 on and a 52 week low of $12.62 on . Vtv Therapeutics Inc stock price today i.e. is closed at $20.25,which is 24.97% down from its 52 week high and 60.46% up from its 52 week low.
Vtv Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Vtv Therapeutics Inc (VTVT) shares with as little as ₹87.954 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Vtv Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Vtv Therapeutics Inc share’s latest price of $20.25 as on October 18, 2025 at 1:27 am IST, you will get 0.4938 shares of Vtv Therapeutics Inc. Learn more about
fractional shares .
Vtv Therapeutics Inc stock has given -70.42% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?